Comparing EQ-5D valuation studies: A systematic review and methodological reporting checklist

Medical Decision Making

Volumn 34, Issue 1, 2014, Pages 8-20

  Xie, Feng ^a,b   Gaebel, Kathryn ^b   Perampaladas, Kuhan ^a,b   Doble, Brett ^a,b,c   Pullenayegum, Eleanor ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MONASH UNIVERSITY   (Australia)

Author keywords

EQ 5D; health utility; reporting checklist; scoring algorithm; valuation

Indexed keywords

ALGORITHM; COMPARATIVE STUDY; EQ-5D; HEALTH UTILITY; HUMAN; QUALITY OF LIFE; REPORTING CHECKLIST; REVIEW; SCORING ALGORITHM; THEORETICAL MODEL; VALUATION; VISUAL ANALOG SCALE;

EQ-5D; HEALTH UTILITY; REPORTING CHECKLIST; SCORING ALGORITHM; VALUATION;

ALGORITHMS; HUMANS; MODELS, THEORETICAL; QUALITY OF LIFE; VISUAL ANALOG SCALE;

EID: 84890636182     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X13480852     Document Type: Review

References (39)

1. Brauer CA, Rosen AB, Greenberg D, Neumann PJ. Trends in the measurement of health utilities in published cost-utility analyses. Value Health. 2006 ; 9 (4). 213-8
2. Brooks R. EuroQol: the current state of play. Health Policy. 1996 ; 37 (1). 53-72
3. Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011 ; 20 (10). 1727-36
4. Essink-Bot ML, Stuifbergen MC, Meerding WJ, Looman CW, Bonsel GJ. Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study. BMC Health Serv Res. 2007 ; 7: 62
5. Busschbach J, Weijnen T, Nieuwenhuizen M The Measurement and Valuation of Health Status EQ-5D: A European Perspective. Brooks R Rabin R de Charro F, ed. Dordrecht, the Netherlands: Kluwer Academic ; 2003: 143-65.
6. Badia X, Roset M, Herdman M, Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making. 2001 ; 21 (1). 7-16
7. Norman R, Cronin P, Viney R, King M, Street D, Ratcliffe J. International comparisons in valuing EQ-5D health states: a review and analysis. Value Health. 2009 ; 12 (8). 1194-200
8. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997 ; 35 (11). 1095-108
9. Kind P. Valuing health benefits using EQ-5D: the West Lothian question. Poster presented at: Plenary Meeting of the EuroQol Group ; 2005 Oslo, Norway ; 2005..
10. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005 ; 43 (3). 203-20
11. Zarate V, Kind P, Chuang LH. Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans. Value Health. 2008 ; 11 (7). 1170-7
12. Shaw JW, Pickard AS, Yu S, et al. A median model for predicting United States population-based EQ-5D health state preferences. Value Health. 2010 ; 13 (2). 278-88
13. Jo MW, Yun SC, Lee SI. Estimating quality weights for EQ-5D health states with the time trade-off method in South Korea. Value Health. 2008 ; 11 (7). 1186-9
14. Lee Y-K, Nam H-S, Chuang L-H, et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health. 2009 ; 12 (8). 1187-93
15. Chang T-J, Tarn Y-H. Selecting a proper EQ-5D value set model for Taiwan population. Poster presented at: Plenary Meeting of the EuroQol Group ; 2005 Oslo, Norway ; 2005..
16. Augustovski FA, Irazola VE, Velazquez AP, Gibbons L, Craig BM. Argentine valuation of the EQ-5D health states. Value Health. 2009 ; 12 (4). 587-96
17. Golicki D, Jakubczyk M, Niewada M, Wrona W, Busschbach JJV. Valuation of EQ-5D health states in Poland: first TTO-based social value set in central and Eastern Europe. Value Health. 2010 ; 13 (2). 289-97
18. Bansback N, Tsuchiya A, Brazier J, Anis A. Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies. PLoS One. 2012 ; 7 (2). e31115
19. Viney R, Norman R, King MT, et al. Time trade-off derived EQ-5D weights for Australia. Value Health. 2011 ; 14 (6). 928-36
20. Chevalier J, de Pouvourville G. Valuing EQ-5D using time trade-off in France. Eur J Health Econ. 2013 ; 14: 57-66
21. Greiner W, Claes C, Busschbach JJ, von der Schulenburg JM. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ. 2005 ; 6 (2). 124-30
22. Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006 ; 15 (10). 1121-32
23. Tongsiri S, Cairns J. Estimating population-based values for EQ-5D health states in Thailand. Value Health. 2011 ; 14 (8). 1142-5
24. Jelsma J, Hansen KS, De WW, De CP, Kind P. How do Zimbabweans value health states?. Popul Health Metr. 2003 ; 1: 11
25. Zarate V, Kind P, Valenzuela P, Vignau A, Olivares-Tirado P, Munoz A. Social valuation of EQ-5D health states: the Chilean case. Value Health. 2011 ; 14 (8). 1135-41
26. Tsuchiya A, Ikeda S, Ikegami N, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002 ; 11 (4). 341-53
27. Claes CH, Greiner W, Uber A, Graf von der Schulenburg JM. An interview-based comparison of the TTO and VAS values given to EQ-5D states of health by the general German population. Poster presented at: Plenary Meeting of the EuroQol Group ; 1998 Hannover, Germany ; 1998..
28. Leidl R, Reitmeir P. A value set for the EQ-5D based on experienced health states: development and testing for the German population. Pharmacoeconomics. 2011 ; 29 (6). 521-34
29. Greiner W, Weijnen T, Nieuwenhuizen M, et al. A single European currency for EQ-5D health states: results from a six-country study. Eur J Health Econ. 2003 ; 4 (3). 222-31
30. Md Yusof FA, Goh A, Azmi S. Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods. Value Health. 2012 ; 15: S85-90
31. Final Report on the Modelling of Valuation Tariffs. York, UK: Centre for Health Economics, University of York ; 1995 :
32. Cleemput I. A social preference valuations set for EQ-5D health states in Flanders, Belgium. Eur J Health Econ. 2010 ; 11 (2). 205-13
33. Devlin NJ, Hansen P, Kind P, Williams A. Logical inconsistencies in survey respondents' health state valuations - a methodological challenge for estimating social tariffs. Health Econ. 2003 ; 12 (7). 529-44
34. Ohinmaa A, Eija H, Sintonen H. Modelling EuroQol values of the Finnish adult population. Poster presented at: Plenary Meeting of the EuroQol Group ; 1995 Barcelona, Spain ; 1995..
35. Rupel VP, Rebolj M. The Slovenian VAS tariff based on valuations of EQ-5D health states from the general population. Poster presented at: Plenary Meeting of the EuroQol Group ; 2000 Pamplona, Spain ; 2000..
36. Wittrup-Jensen KU, Lauridsen J, Gudex C, Pedersen KM. Generation of a Danish TTO value set for EQ-5D health states. Scand J Public Health. 2009 ; 37 (5). 459-66
37. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 2001 ; 285 (15). 1987-91
38. Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA. 2001 ; 285 (15). 1992-5
39. Gerson LB, Ullah N, Hastie T, Triadafilopoulos G, Goldstein M. Patient-derived health state utilities for gastroesophageal reflux disease. Am J Gastroenterol. 2005 ; 100 (3). 524-33